A BOSEIN cross-linked product, a soluble microneedle patch, and preparation method and application thereof
The hydroxypropyltetrahydropyrantriol/hydrolyzed collagen composite crosslinked sol was generated through irradiation modification technology, achieving sustained release of microneedle active ingredients, solving the problem of short action time of bosein and hydrolyzed collagen , significantly improves the beauty and skin care effect and extends the time of action.
Patent Information
- Application Number
- CN202310798352.5
- Authority / Receiving Office
- CN · China
- Patent Type
- Patents(China)
- Current Assignee / Owner
- Filing Date
- 2023-06-30
- Publication Date
- 2024-11-05
- Estimated Expiration
- 2043-06-30
AI Technical Summary
In the prior art, the time of action of bose and hydrolyzed collagen in the skin is limited, resulting in the short-term effect of the cosmetic and skin care microneedle patch and cannot be effectively extended.
The hydrolyzed collagen and hydroxypropyltetrahydropyrantriol complex system is treated through controllable radiation modification technology to generate hydroxypropyltetrahydropyrantriol/hydrolyzed collagen complex crosslinked sol to achieve slowdown of the active ingredient Release the effect.
It significantly extends the synergistic effect of active ingredients in the skin, improves the beauty and skin care effect of micro-needle patches, and the cumulative release percentage still reaches 70% after 48 hours, solving the problem of limited time for traditional micro-needle patches.
Smart Images

Figure CN116831940B_ABST
Abstract
Description
Technical Field
[0001] The present invention relates to the technical field of beauty and skin care, and in particular to a botoxetine cross-linked product, a long-lasting beauty and skin care soluble microneedle patch and a preparation method thereof. Background Art
[0002] Proxylan, also known as PRO-XYLANE, is called "hydroxypropyl tetrahydropyrantriol" in Chinese. Its Chemical Abstract Number (CAS Number) is 439685-79-7. It is a xylose derivative with anti-aging active ingredients. It can promote the synthesis of hyaluronic acid, chondroitin sulfate and other aminoglucans, as well as type I and type IV collagen in skin cells, thereby improving skin elasticity, relieving skin wrinkles, and skin repair. Hydrolyzed collagen is a water-soluble polypeptide obtained by hydrolysis of animal collagen as a raw material. The molecular weight is generally less than 5000Da. Because of its similar structure to human skin collagen, it can provide the required amino acid sources such as glycine, proline and hydroxyproline for the synthesis of human skin collagen. As an active ingredient, it can promote collagen synthesis, increase skin firmness and elasticity, and delay skin aging. The synergistic use of these two active ingredients can play a better cosmetic effect of improving skin elasticity and relieving wrinkles. In the prior art, when Bossagra and hydrolyzed collagen are used in combination to prepare beauty and skin care products, such as microneedle patches, the active ingredients will be quickly depleted, so the duration of action is very limited.
[0003] Microneedle patch is a new type of transdermal delivery system composed of an array of micron-sized needle tips (needle body) and a base film. Its microneedle array can penetrate the skin stratum corneum barrier through mechanical action and temporarily form micron-sized channels on the skin surface, thereby increasing the skin's absorption and utilization of cosmetic active substances, thereby achieving whitening, lightening spots and reducing wrinkles. At the same time, the controllable small-sized microneedle array can avoid the capillaries and nerve endings in the dermis, and the resulting tiny skin wounds can also heal quickly. Therefore, microneedle patches are regarded as a safe, minimally invasive and efficient transdermal delivery system for use in the field of beauty and skin care, including non-absorbable microneedle patches such as metal microneedles, and soluble microneedle patches constructed with hydrophilic degradable polymer materials as the substrate, etc. Among them, soluble microneedle patches with degradable water-soluble polymer materials such as hyaluronic acid (more commonly referred to as "hyaluronic acid" in the commercial field) as the matrix that carry beauty and skin care active ingredients are particularly concerned by the home beauty market. Specifically, the soluble microneedle patch consists of an array of micron-sized needle tips (needle body) and a base film (formed by solidifying the base liquid); the loading solution in the needle body is usually a hyaluronic acid aqueous solution, and other skin care active ingredients can also be added.
[0004] However, as a minimally invasive product, frequent use of microneedle patches may still cause adverse consequences such as inflammation to certain susceptible skin. It is necessary to extend their duration of action while improving the efficacy of the active substances they carry, thereby increasing user compliance.
[0005] In the current prior art, there are sustained-release solutions of hyaluronic acid and hydrolyzed collagen, such as the one disclosed in Chinese patent CN115737912A, which uses a chemical method to emulsify and cross-link the active ingredients to form a sodium hyaluronate microsphere, thereby achieving a sustained-release effect. Chinese patent CN113368034A discloses another technical solution, which adds a sustained-release drug vesicle to the microneedle, and the drug is wrapped in the vesicle, thereby delaying the release of the drug. It can be seen that the research direction of the current technical solution is mainly to use the special structure formed by the compound to wrap the active ingredient, thereby delaying the release. However, this technical solution requires the additional addition of chemical excipients to form a special structure, and reduces the content of the active ingredient in the microneedle patch. Summary of the invention
[0006] The technical problem to be solved by the present invention is to overcome the problem of limited action time of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen in the skin in the prior art, and to provide a long-lasting beauty and skin care soluble microneedle patch, based on which a synergistic action time of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen delivered by microneedles in the skin is increased, thereby prolonging and improving the effect of the microneedle patch.
[0007] The purpose of the present invention is to provide a sustained-release bosera cross-linked product and a preparation method and application thereof.
[0008] The second object of the present invention is to provide a needle body solution for preparing a microneedle patch and a preparation method and application thereof.
[0009] The third object of the present invention is to provide a soluble microneedle patch and its application in beauty and skin care.
[0010] The above-mentioned object of the present invention is achieved through the following technical solutions:
[0011] The present invention creatively processes a composite system of hydrolyzed collagen and hydroxypropyl tetrahydropyrantriol through a controllable irradiation modification technology to generate free radicals, and can induce the self-crosslinking of hydrolyzed collagen and combine with hydroxypropyl tetrahydropyrantriol without using chemical reagents, thereby obtaining a hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite crosslinked sol. The active ingredients of the composite crosslinked sol have a sustained release effect, and can significantly improve the efficacy of the active ingredients in promoting cell synthesis of type I collagen.
[0012] The invention provides a bosin cross-linked product, which is a hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol formed by cross-linking hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen through irradiation of rays.
[0013] Preferably, the mass ratio of hydroxypropyl tetrahydropyrantriol to hydrolyzed collagen is (0.5-5):(1-6).
[0014] More preferably, the mass ratio of hydroxypropyl tetrahydropyrantriol to hydrolyzed collagen is (0.5-2):(1-5).
[0015] Preferably, the radiation is 60 Co-gamma rays or electron beams.
[0016] Preferably, the irradiation dose is 12 to 40 kGy. More preferably, the irradiation dose is 15 to 40 kGy.
[0017] In a specific operation, preferably, hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen are first mixed and dissolved in water, and then irradiated with radiation.
[0018] Preferably, the mass ratio of hydroxypropyl tetrahydropyrantriol, hydrolyzed collagen and water is (0.5-5):(1-6):10.
[0019] More preferably, the mass ratio of hydroxypropyl tetrahydropyrantriol, hydrolyzed collagen and water is (0.5-2):(1-5):10.
[0020] In addition, the hydroxypropyl tetrahydropyrantriol contains two stereostructures: levorotatory (S configuration) and dextrorotatory (R configuration). In the present application, preferably, the ratio of S / R is between 20 / 80 and 50 / 50, and more preferably between 40 / 60 and 50 / 50.
[0021] The present invention also provides the use of the above-mentioned cross-linked bosin in the preparation of cosmetics, medical devices or drugs (especially medical devices or drugs for medical beauty), such as non-invasive soluble microneedle patches, facial masks, eye creams, face creams, essences, cleansing milks, stock solutions, toners, sunscreens and other products.
[0022] The invention provides a needle body solution for preparing a microneedle patch, which contains the above-mentioned BOXYL cross-linked product (ie, hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol) and a matrix solution.
[0023] Preferably, the volume ratio of hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linking sol to the matrix solution is (5-10): (5-10).
[0024] The matrix solution is a matrix solution used in the prior art for preparing a microneedle patch. Specifically, the matrix solution is an aqueous solution containing a water-soluble polymer material, or an aqueous solution containing a water-soluble polymer material and an auxiliary material.
[0025] The water-soluble polymer material is hyaluronic acid, polyglutamic acid and the like.
[0026] The auxiliary material is any one or more of polyethylene glycol, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, carboxymethyl chitosan or carboxymethyl cellulose.
[0027] The concentration of the water-soluble polymer material in the matrix solution is 5% to 40% (m / V), and the concentration of the auxiliary material is 5% to 15% (m / V).
[0028] Preferably, the concentration of hyaluronic acid in the matrix solution is 15% to 30% (m / V), and the concentration of polyglutamic acid is 10% to 20% (m / V).
[0029] The present invention also provides application of the needle solution in preparing a microneedle patch.
[0030] The present invention also provides a long-lasting beauty and skin care soluble microneedle patch, comprising the above-mentioned needle body solution and base liquid.
[0031] The base liquid is the base liquid used in the prior art for preparing microneedle patches. Commonly used base liquids are aqueous solutions of polyvinyl pyrrolidone and polyvinyl alcohol.
[0032] Furthermore, the mass ratio of the components in the base liquid is: polyvinyl pyrrolidone: polyvinyl alcohol: water = (0.5-1.5): (0.5-1.5): 10.
[0033] Preferably, the mass ratio of the components in the base liquid is: polyvinyl pyrrolidone: polyvinyl alcohol: water = 1:1:10.
[0034] In addition, the present invention also provides an optional implementation scheme, the preparation method of the long-lasting beauty and skin care soluble microneedle patch, the specific steps are:
[0035] S1: preparing hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen into an aqueous solution, deoxygenating and sealing;
[0036] S2: irradiating the composite aqueous solution of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen with high-energy rays to cross-link them, thereby obtaining a hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol;
[0037] S3: fully mixing the hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linking sol with the matrix solution to obtain a needle solution;
[0038] S4: Add the obtained needle body solution and microneedle patch base liquid into the microneedle patch mold in sequence, solidify and shape, and demold to obtain a soluble microneedle patch.
[0039] More specifically, the steps of sequentially adding in step S4 are firstly pouring the needle body solution into the microneedle patch mold, solidifying and forming the needle body; and then pouring the base liquid into the microneedle patch mold containing the molded needle body, solidifying and forming the needle body.
[0040] Furthermore, in the preparation method, the deoxygenation method in step S1 is to evacuate the air and introduce an inert gas for deoxygenation, and the inert gas is nitrogen or argon.
[0041] Furthermore, in the preparation method, the material of the microneedle patch mold in step S4 is polydimethylsiloxane (PDMS).
[0042] Furthermore, in the preparation method, the specific method of curing and molding in step S4 is vacuum drying.
[0043] Finally, the present invention provides the application of the above-mentioned soluble microneedle patch in beauty and skin care.
[0044] The present invention also provides the use of the bosogenin cross-linked product, the needle solution or the soluble microneedle patch in preparing a product having the effect of promoting cell synthesis of type I collagen.
[0045] In the technical scheme of the present invention, in which a soluble microneedle patch is prepared by compounding cross-linked sol of sorbin and hydrolyzed collagen with hyaluronic acid (hyaluronic acid) aqueous solution, sorbin, hydrolyzed collagen, and hyaluronic acid (hyaluronic acid) together constitute the most basic and important matrix material system of soluble microneedle patches for beauty and skin care. After reasonable and sophisticated matching, they form a matrix material system with significant moisturizing and anti-aging effects, which we call the "double glass" system. In practice, the "double glass" system has a significant "broad spectrum", that is, on the basis of this system, by adding other different functional components, various soluble microneedle products with different functions can be prepared, such as soluble microneedle products for removing acne, removing wrinkles, anti-aging, lightening spots, removing spots, whitening, etc.
[0046] Compared with the prior art, the present invention has the following beneficial effects:
[0047] The scheme of the present invention can induce the self-crosslinking of hydrolyzed collagen and combine hydroxypropyl tetrahydropyrantriol by controllable irradiation technology without using chemical reagents, and obtain a bosaiin crosslinked product (hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite crosslinked sol). The active ingredients of the composite crosslinked sol obtain a sustained release effect, and can significantly improve the efficacy of the active ingredients in promoting cell synthesis of type I collagen. The composite crosslinked sol is added to a microneedle patch as an active ingredient to obtain a long-lasting beauty and skin care soluble microneedle patch. It was found through testing that the long-lasting beauty and skin care soluble microneedle patch still has a drug effect after 48 hours of action, and the cumulative release percentage is about 70%; in contrast, the microneedle patch directly loaded with active substances has almost exhausted its drug effect after 3 hours of action, and the cumulative release percentage is about 97%. It can be seen that the above-mentioned Bossagra cross-linked product significantly prolongs the synergistic action time of the active ingredients after being loaded into the skin through the microneedle patch, solving the problem of limited action time of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen directly loaded by the traditional microneedle patch; it can significantly improve the beauty and skin care effect of the microneedle patch, and can also be used in the preparation of other skin care products, medical beauty products or drugs, and the preparation process is simple, the safety is good, and it has good application prospects in skin care and beauty. BRIEF DESCRIPTION OF THE DRAWINGS
[0048] Figure 1 This is a scanning electron microscope photograph of the hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol obtained by irradiation treatment.
[0049] Figure 2 This is a scanning electron microscope photo of the soluble microneedle patch.
[0050] Figure 3 This is a comparison chart of the in vitro release behavior of hydroxypropyl tetrahydropyrantriol from the soluble microneedle patch.
[0051] Figure 4 Comparison of the efficacy of soluble microneedle patches. DETAILED DESCRIPTION
[0052] The present invention is further described below in conjunction with the accompanying drawings and specific examples, but the examples do not limit the present invention in any form. Unless otherwise specified, the reagents, methods and equipment used in the present invention are conventional reagents, methods and equipment in the art.
[0053] Unless otherwise specified, the reagents and materials used in the following examples are commercially available.
[0054] Example 1 Long-lasting beauty and skin care soluble microneedle patch
[0055] S1. Preparation of active ingredient complex aqueous solution
[0056] 0.5 g of hydroxypropyl tetrahydropyrantriol (S / R: 40 / 60) and 1.0 g of hydrolyzed collagen were dissolved in 10 mL of deionized water, deoxygenated, and sealed to obtain a composite aqueous solution of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen;
[0057] S2. Irradiation treatment of active ingredients:
[0058] The above-mentioned hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen composite aqueous solution was poured into a film-forming mold that can be penetrated by high-energy rays, evacuated and nitrogen was introduced to deoxygenate, and then sealed; then, an irradiation dose of 40 kGy was used. 60 Co-γ-ray irradiation makes it cross-linked to form hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol.
[0059] Structural characterization of hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol: The cross-sectional scanning electron micrograph of the hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol prepared above after vacuum freeze drying is shown in Figure 1 The cross section shows a three-dimensional porous network cross-linked structure morphology.
[0060] S3. Preparation of needle solution:
[0061] Take 10 mL of the above hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol and mix it evenly with 10 mL of 20% (m / V) hyaluronic acid aqueous solution to obtain a needle solution;
[0062] S4. Preparation of microneedle patch:
[0063] S41. Pour the needle solution into the PDMS microneedle patch mold and vacuum dry to obtain a needle body;
[0064] S42. Dissolve 1g of polyvinyl pyrrolidone and 1g of polyvinyl alcohol in 10mL of deionized water and stir to mix well to obtain a base solution;
[0065] S43. Pour the base liquid into the above-mentioned PDMS microneedle patch mold containing the molded needle body, vacuum dry and shape it, and demold it to obtain a soluble microneedle patch.
[0066] The morphology of the obtained soluble microneedle patch was observed by scanning electron microscopy. Figure 2 , indicating that the microneedle array was successfully obtained according to the above method.
[0067] Example 2 Long-lasting beauty and skin care soluble microneedle patch
[0068] S1. Preparation of active ingredient complex aqueous solution
[0069] Take 2 g of hydroxypropyl tetrahydropyrantriol (S / R: 50 / 50) and 5 g of hydrolyzed collagen and dissolve them in 10 mL of deionized water, deoxygenate and seal to obtain a composite aqueous solution of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen;
[0070] S2. Irradiation treatment of active ingredients:
[0071] The above-mentioned hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen composite aqueous solution was poured into a film-forming mold that can be penetrated by high-energy rays, evacuated and nitrogen was introduced to deoxygenate, and then sealed; then, an irradiation dose of 15 kGy was used. 60 Co-γ-ray irradiation makes it cross-linked to form hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol.
[0072] S3. Preparation of needle solution:
[0073] Take 5 mL of the above hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol and mix it evenly with 10 mL of 30% (m / V) hyaluronic acid aqueous solution to obtain a needle solution;
[0074] S4. Preparation of microneedle patch:
[0075] S41. Pour the needle solution into the PDMS microneedle patch mold and vacuum dry to obtain a needle body;
[0076] S42. Dissolve 1g of polyvinyl pyrrolidone and 1g of polyvinyl alcohol in 10mL of deionized water and stir to mix well to obtain a base solution;
[0077] S43. Pour the base liquid into the above-mentioned PDMS microneedle patch mold containing the molded needle body, vacuum dry and shape it, and demold it to obtain a soluble microneedle patch.
[0078] Example 3 Long-lasting beauty and skin care soluble microneedle patch
[0079] S1. Preparation of active ingredient complex aqueous solution
[0080] Take 1 g of hydroxypropyl tetrahydropyrantriol (S / R: 50 / 50) and 2 g of hydrolyzed collagen and dissolve them in 10 mL of deionized water, deoxygenate and seal to obtain a composite aqueous solution of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen;
[0081] S2. Irradiation treatment of active ingredients:
[0082] The above-mentioned hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen composite aqueous solution was poured into a film-forming mold that can be penetrated by high-energy rays, evacuated and nitrogen was introduced to deoxygenate, and then sealed; then, an irradiation dose of 20 kGy was used. 60 Co-γ-ray irradiation makes it cross-linked to form hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol.
[0083] S3. Preparation of needle solution:
[0084] 5 mL of the above hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol is mixed evenly with 5 mL of an aqueous solution containing 20% (m / V) hyaluronic acid and 10% (m / V) hydroxypropyl cellulose to obtain a needle solution;
[0085] S4. Preparation of microneedle patch:
[0086] S41. Pour the needle solution into the PDMS microneedle patch mold and vacuum dry to obtain a needle body;
[0087] S42. Dissolve 1g of polyvinyl pyrrolidone and 1g of polyvinyl alcohol in 10mL of deionized water and stir to mix well to obtain a base solution;
[0088] S43. Pour the base liquid into the above-mentioned PDMS microneedle patch mold containing the molded needle body, vacuum dry and shape it, and demold it to obtain a soluble microneedle patch.
[0089] Example 4 Long-lasting beauty and skin care soluble microneedle patch
[0090] S1. Preparation of active ingredient complex aqueous solution
[0091] Take 1 g of hydroxypropyl tetrahydropyrantriol (S / R: 50 / 50) and 2 g of hydrolyzed collagen and dissolve them in 10 mL of deionized water, deoxygenate and seal to obtain a composite aqueous solution of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen;
[0092] S2. Irradiation treatment of active ingredients:
[0093] The above-mentioned hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen composite aqueous solution is poured into a film-forming mold that can be penetrated by high-energy rays, evacuated and nitrogen is introduced for deoxygenation, and then sealed; then, an electron beam irradiation with an irradiation dose of 20 kGy is used to cross-link it into a hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol.
[0094] S3. Preparation of needle solution:
[0095] 5 mL of the above hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol is mixed evenly with 5 mL of an aqueous solution containing 15% (m / V) polyglutamic acid to obtain a needle solution;
[0096] S4. Preparation of microneedle patch:
[0097] S41. Pour the needle solution into the PDMS microneedle patch mold and vacuum dry to obtain a needle body;
[0098] S42. Dissolve 1g of polyvinyl pyrrolidone and 1g of polyvinyl alcohol in 10mL of deionized water and stir to mix well to obtain a base solution;
[0099] S43. Pour the base liquid into the above-mentioned PDMS microneedle patch mold containing the molded needle body, vacuum dry and shape it, and demold it to obtain a soluble microneedle patch.
[0100] The scanning electron microscopic photograph of the cross section of the hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol obtained in Example 2-4 after vacuum freeze-drying, and the scanning electron microscopic morphology of the obtained soluble microneedle patch are similar to those in Example 1.
[0101] Then, the in vitro release behavior and efficacy of hydroxypropyl tetrahydropyrantriol of the obtained soluble microneedle patch were studied. Taking Example 2 as an example, a soluble microneedle patch control group without irradiation technology was prepared for comparison. The contents of Examples 5-7 are shown below.
[0102] Example 5: Comparative Example of Soluble Microneedle Patch Without Irradiation Technology
[0103] Referring to the scheme of Example 2, the difference is that the treatment of step S2 is different, and the active ingredients are directly mixed, that is, 2g of hydroxypropyl tetrahydropyrantriol (S / R: 50 / 50) and 5g of hydrolyzed collagen are dissolved in 10mL of deionized water, stirred evenly, and a hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen mixed solution is obtained. The hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen mixed solution obtained is used to replace the hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol, and the other steps are the same as S1, S3-S4. A soluble microneedle patch reference substance without irradiation technology is prepared.
[0104] Example 6 In vitro release behavior of hydroxypropyl tetrahydropyrantriol from soluble microneedle patch
[0105] 0.05 g of the soluble microneedle patches prepared in Example 2 and Example 5 were respectively taken and placed in a dialysis tube (10KMWCO), and then immersed in 50 mL of release medium (normal saline) (37°C water bath agitator, speed 100 rpm), 2 mL of release medium was taken at a set time point, and 2 mL of fresh release medium was added, and the concentration of hydroxypropyl tetrahydropyrantriol was tested by HPLC, and an in vitro release curve was drawn, as shown in FIG. Figure 3 shown.
[0106] As can be seen from the figure, after 3 hours of action, the cumulative release percentage of the microneedle patch of Example 5 without irradiation technology is as high as more than 97%, while the cumulative release percentage of the microneedle patch of Example 2 using irradiation technology is only about 30%, and the cumulative release percentage after 48 hours is only about 70%. It can be seen that the sustained release performance of hydroxypropyl tetrahydropyrantriol in the microneedle patch of Example 2 using irradiation technology is significantly improved compared with the microneedle patch of Example 5 without irradiation technology.
[0107] Example 7 Evaluation of the efficacy of the soluble microneedle patch
[0108] Human skin fibroblasts (HSF) were used as an in vitro model, and the efficacy of the soluble microneedle patch in improving skin was evaluated by detecting the synthesis of type I collagen in HSF cells co-cultured with the soluble microneedle patch.
[0109] Take appropriate amounts of the soluble microneedle patches prepared in Example 2 and Example 5 of the same mass and place them in a 12-well cell culture plate. Use DMEM as the culture medium and incubate HSF cells at a rate of 5×10 4 The cells were inoculated at a density of 1000 / well and cultured for 48 hours. The culture medium was collected, and the blank control group was HSF cell culture medium without soluble microneedle stickers. The type I collagen content in the supernatant was detected using an ELISA kit.
[0110] The results are as follows Figure 4 As shown, the concentration of type I collagen in the culture medium of HSF cells treated with the microneedle patch of Example 2 using the irradiation technology was significantly increased compared with that of Example 5 not using the irradiation technology. It can be seen that the microneedle patch of Example 2 using the irradiation technology has a better effect of promoting the synthesis of type I collagen in HSF cells compared with the microneedle patch of Example 5 not using the irradiation technology.
[0111] Finally, it should be noted that the above embodiments are only used to illustrate the technical solutions of the present invention rather than to limit the protection scope of the present invention. For ordinary technicians in this field, other different forms of changes or modifications can be made based on the above descriptions and ideas. It is not necessary and impossible to list all the implementation methods here. Any modifications, equivalent substitutions and improvements made within the spirit and principles of the present invention should be included in the protection scope of the claims of the present invention.
Claims
1. A boson cross-linked product, characterized in that: The hydroxypropyl tetrahydropyrantriol / hydrolyzed collagen composite cross-linked sol is prepared by cross-linking hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen by irradiation with radiation; the radiation is 60 Co-gamma rays or electron beams.
2. The cross-linked boson according to claim 1, characterized in that: The mass ratio of hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen is (0.5-5): (1-6).
3. The boson cross-linked product according to claim 1, characterized in that: The irradiation dose is 12 to 40 kGy.
4. The cross-linked boson according to any one of claims 1 to 3, characterized in that: Hydroxypropyl tetrahydropyrantriol and hydrolyzed collagen are first mixed and dissolved in water, and then irradiated with radiation.
5. The cross-linked boson according to claim 4, characterized in that: The mass ratio of hydroxypropyl tetrahydropyrantriol, hydrolyzed collagen and water is (0.5-5):(1-6):
10.
6. Use of the cross-linked bosogenin according to any one of claims 1 to 5 in the preparation of cosmetics, medical devices or medicines.
7. A needle solution for preparing a microneedle patch, characterized in that: Contains the bosogenin cross-linked product according to any one of claims 1 to 5 and a matrix solution.
8. A long-lasting beauty and skin care soluble microneedle patch, characterized in that: It comprises the needle solution and base solution as described in claim 7.
9. Use of the bosin cross-linked product according to any one of claims 1 to 5, the needle solution according to claim 7, or the soluble microneedle patch according to claim 8 in the preparation of a product having the effect of promoting cell synthesis of type I collagen.
